New Regulations Require Doctor's Prescription for Cough Syrups in India

In a significant regulatory shift, India's Ministry of Health has mandated that all cough syrups and similar medications can only be purchased with a doctor's prescription. This decision follows alarming reports linking the deaths of children to low-quality cough syrups, prompting a reevaluation of safety standards in the pharmaceutical industry. Effective from June 9, 2026, this new rule aims to ensure better oversight and quality control in the sale of liquid medications. As a result, consumers will need to present valid prescriptions when buying these products, which could drastically change the accessibility of cough syrups that were previously available over-the-counter. Read on to learn more about the implications of this new regulation.

By Narendra Chaudhary Jun 16, 2026, 12:22 IST

Mandatory Prescription for Cough Syrups

The Ministry of Health and Family Welfare has announced a new regulation mandating that customers must obtain a doctor's prescription to purchase any type of syrup, including cough syrups, from pharmacies across the country. Following this notification, these medications will no longer be available over-the-counter (OTC) without a doctor's prescription. Customers will now need to present a valid prescription from a registered physician to buy such syrups. This notification, effective from June 9, 2026, was issued after the government reviewed public feedback on a draft proposal released last December. As part of this change, the term 'syrup' has been removed from the category of drugs listed in Schedule K of the Drugs Rules, leading to the cessation of OTC sales for syrups, which will now be subject to stricter regulatory requirements.

Regulatory Changes Under the Drugs and Cosmetics Act

According to the notification, the central government has exercised its powers under Sections 12 and 33 of the Drugs and Cosmetics Act of 1940 to amend the Drugs Rules of 1945. The notification states that these regulations may be referred to as the Drugs (Fifth Amendment) Rules, 2026, and will come into effect from the date of their publication in the official gazette.

Concerns Over Cough Syrup Safety

This decision comes in the wake of allegations linking the deaths of several children in Madhya Pradesh and Rajasthan to substandard cough syrups. These incidents have reignited concerns regarding the safety and regulatory oversight of widely used liquid medications. Following these events, there has been a renewed call for stringent quality checks and controls in the manufacturing, distribution, and sale of syrup-based medications.

Impact on Consumers

The regulatory change means that common cough medications, along with all syrups, will no longer be available without a doctor's advice or prescription. Customers will now be required to show a valid prescription from a registered doctor when purchasing these medications from pharmacies. It is anticipated that this decision will significantly impact the general sale of cough syrups and other medicinal syrups that were previously easily accessible without a prescription.